Institute of Biochemical Sciences and Technology, Chaoyang University of Technology, 168 Gofeng E Road, Wufeng 41349, Taiwan.
Evid Based Complement Alternat Med. 2011;2011:624375. doi: 10.1093/ecam/nep204. Epub 2011 Mar 10.
Citrus grandis (L.) Osbeck (red wendun) leaves have been used in traditional Chinese medicine to treat several illnesses including diabetes. However, there is no scientific evidence supporting these actions and its active compounds. Two flavone glycosides, rhoifolin and cosmosiin were isolated for the first time from red wendun leaves and, identified these leaves are rich source for rhoifolin (1.1%, w/w). In differentiated 3T3-L1 adipocytes, rhoifolin and cosmosiin showed dose-dependent response in concentration range of o.oo1-5 μM and 1-20 μM, respectively, in biological studies beneficial to diabetes. Particularly, rhoifolin and cosmosiin at 0.5 and 20 μM, respectively showed nearly similar response to that 10 nM of insulin, on adiponectin secretion level. Furthermore, 5 μM of rhoifolin and 20 μM of cosmosiin showed equal potential with 10 nM of insulin to increase the phosphorylation of insulin receptor-β, in addition to their positive effect on GLUT4 translocation. These findings indicate that rhoifolin and cosmosiin from red wendun leaves may be beneficial for diabetic complications through their enhanced adiponectin secretion, tyrosine phosphorylation of insulin receptor-β and GLUT4 translocation.
柚(Citrus grandis (L.) Osbeck)叶在传统中药中被用于治疗多种疾病,包括糖尿病。然而,目前没有科学证据支持这些作用及其活性化合物。首次从红橘叶中分离得到两种黄酮糖苷,柚皮苷和新橙皮苷,并鉴定出这些叶子是柚皮苷的丰富来源(1.1%,w/w)。在分化的 3T3-L1 脂肪细胞中,柚皮苷和新橙皮苷在生物研究中对糖尿病有益,在 0.001-5 μM 和 1-20 μM 的浓度范围内分别表现出剂量依赖性反应。特别是,柚皮苷和新橙皮苷在 0.5 和 20 μM 时,对脂联素分泌水平的反应与 10 nM 胰岛素几乎相似。此外,5 μM 的柚皮苷和 20 μM 的新橙皮苷与 10 nM 胰岛素具有相同的潜力,可增加胰岛素受体-β的磷酸化,同时对 GLUT4 易位也有积极作用。这些发现表明,红橘叶中的柚皮苷和新橙皮苷可能通过增强脂联素分泌、胰岛素受体-β酪氨酸磷酸化和 GLUT4 易位对糖尿病并发症有益。